Aspira Women’s Health Inc. (AWH)

AWH Chart as of 2025-03-11

AWH Chart

Stock Information

CEO:	–
CFO:	–
Employees:	64
Address:	Building III, Austin, TX, United States
Country:	United States
Website:	https://aspirawh.com
Listing Date:	–
Founded:	–
Founder:	–
Current Price:	0.3984 USD
Today Change:	99.20%
Outstanding Shares:	17,675,000
Volume:	1,201,714
Avg Volume:	329,255
Expert Target Price:	5.5000 (Institutions: 0)
EPS:	–
PER:	–
Dividend Date:	–
Last Split Date:	2023-05-12
Last Split Factor:	1:15

Key Executives

Name	Title	Pay	Year
Mr. Michael Buhle	CEO & Chief Commercial Officer	—	—
Mr. James Crawford	VP of Finance & Principal Accounting Officer	—	—
Ms. Nicolette Possemato	Senior Vice President of Human Resources	—	—
Ms. Michelle Snider	Senior Vice President of Commercial Strategy & Operations	—	—
Ms. Jamie L. Sullivan	Chief of Staff & ARPA-H Program Director	—	—

Financials

Income Statement

Metric	Amount
Total Revenue	nan
Cost Of Revenue	nan
Gross Profit	nan
Operating Income	nan
Net Income	nan

Balance Sheet

Metric	Amount
Total Assets	nan
Total Liabilities	–
Total Stockholder Equity	–

Cash Flow

Metric	Amount
Total Cash From Operating Activities	–
Capital Expenditures	–

SEC Filings (Gemini Summaries)

AccNo	Date	Summary
0000908834-25-000098	2025-03-10	Form 4 filing for Aspira Women’s Health (AWH) by Jack W. Schuler, director and 10% owner. Earliest transaction date: 03/06/2025. Reports ownership of 6,536 shares directly and 1,912,156 indirectly via a living trust.
0000908834-25-000097	2025-03-10	This SEC filing text defines CSS styles for textboxes and tables. Table styles include borders, padding, font size/weight, color, alignment, and word wrapping. Styles differentiate left, right, and inner elements.
0001172661-25-001252	2025-02-14	This SEC filing text defines CSS styles for text boxes and tables. It specifies borders, padding, font sizes, colors, and alignment for various table elements (th, td) and a fake text box.
0001493152-25-006890	2025-02-14	Aspira Women’s Health (AWH) filed an 8-K on 2/14/25, reporting Nasdaq delisting notice on 2/11/25 for violating Listing Rule 5635(c) due to a private placement below market value without shareholder approval. AWH amended warrants to regain compliance; the matter is closed.
0001493152-25-006236	2025-02-13	Aspira Women’s Health requests withdrawal of its S-1 registration (File No. 333-284182) because they will not pursue a public offering due to other opportunities. No securities were sold, and they request fees be credited for future filings.

News Summary

– Hearts Melt As Pregnant Rescue Cat Sees Her Ultrasound for the First Time
2025-02-27 09:47:10 | Newsweek
“Awh the was she looked at the screen as if to say look at my babies,” one user commented under the viral video.
Link

– I’m tired of waiting for AMD’s entry-level Ryzen 9000 series chips
2025-02-24 17:39:20 | TechRadar
AMD is taking too long with its budget Ryzen 9000 CPUs, and I’m starting to get impatient.
Link

– Neural mechanisms of learned suppression uncovered by probing the hidden attentional priority map
2025-02-26 00:00:00 | Elifesciences.org
Attentional capture by an irrelevant salient distractor is attenuated when the distractor appears more frequently in one location, suggesting learned suppression of that location. However, it remains unclear whether suppression is proactive (before attention …
Link

Analysis of Today’s Move

**Aspira Women’s Health (AWH) Stock Rally Analysis**

The AWH stock rally today is likely not related to any cat ultrasounds. Consumer hardware frustrations regarding AMD chips are also irrelevant. Advances in understanding neural mechanisms have no bearing. Instead, factors from the SEC filings are more likely the drivers.

The most probable cause is the resolution of the Nasdaq delisting notice. AWH’s 8-K filing on February 14th reported the initial notice. The company violated listing rules by issuing a private placement. They amended warrants to regain compliance, closing the matter.

This resolution removes a significant overhang on the stock. Investors likely perceived the delisting threat as a major risk. Clearing this hurdle would increase investor confidence considerably. This, in turn, could drive buying pressure and the stock price up.

The Form 4 filing by Jack W. Schuler is a potential supporting factor. His reported ownership, both direct and indirect, shows confidence. This insider ownership may signal positive future prospects. This can influence other investors to buy the stock.

Finally, the withdrawal of the S-1 registration might be interpreted positively. It indicates AWH found alternative funding, removing dilution fears. This could be viewed as strategic, lessening the need for a public offering. This might signal better financial health than initially perceived.

This stock has shown a change of 99.20% today.
Please consider that all investment decisions carry risk;
none of the content here should be construed as financial advice.
Always do your own research or consult a professional before making investment decisions.

The information provided in this article is for informational purposes only
and does not constitute legal, tax, or investment advice.
Investing involves risk, including the potential loss of principal.

[TSX Venture Exchange] Aspira Women’s Health Inc. (AWH) +99.20% : Pre-market : Hearts Melt As Pregnant Rescue Cat Sees Her Ultrasound for the First Time (2025-03-11)